Long-term use of antiplatelet drugs by stroke patients: A follow-up study based on prescription register data

European Journal of Clinical Pharmacology

Volumn 68, Issue 12, 2012, Pages 1631-1637

  Østergaard, Kamilla ^a,b   Hallas, Jesper ^c   Oren Bak S ^a   DePont Christensen, René ^c   Gaist, David ^a,b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Antiplatelet; Non persistence; Stroke; Stroke prevention

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; DISEASE SEVERITY; DRUG USE; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HEALTH BEHAVIOR; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PATIENT COMPLIANCE; POLYPHARMACY; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SMOKING; STROKE PATIENT; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; STROKE;

EID: 84871339200     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-012-1293-7     Document Type: Article

References (17)

1. Sappok T, Faustich A, Stuckert E, Kruck H,Marx P, Koennecke H-C (2001) Compliance with secondary prevention of ischemic stroke. Stroke 32:1884-1889
2. Hamann GF, Weimar C, Glahn J et al (2003) Adherence to secondary stroke prevention strategies - results from the German Stroke Data Bank. Cerebrovasc Dis 15:282-288
3. Burke JP, Sander S, Shah H et al (2010) Impact of persistence with antiplatelet therapy on recurrent ischemic stroke and predictors of nonpersistence among ischemic stroke survivors. Curr Med Res Opin 26:1023-1030
4. Glader E-L, Sjölander M, Eriksson M, Lundberg M (2010) Persistent use of secondary preventive drugs decline rapidly during the first 2 years after stroke. Stroke 41:397-401
5. Bushnell CD, Olson DM, Zhao X et al (2011) Secondary preventive medication persistence and adherence 1 year after stroke. Neurology 77:1182-1190
6. Bak S, Sindrup SH, Alslev T et al (2002) Cessation of smoking after first-ever stroke - a follow-up study. Stroke 33:2263-2269
7. World Health Organisation (1989) Recommendations on stroke prevention, diagnosis and therapy. Stroke 20:1407-1431
8. Goldstein LB, Bertels C, Davis JN (1989) Interrater reliability of the NIH Stroke Scale. Arch Neurol 46:660-662
9. Gaist D, Sørensen HT, Hallas J (1997) The Danish prescription registries. Dan Med Bull 44:445-448
10. WHO Collaborating Centre for Drug Statistics Methodology (2000) Anatomical therapeutic chemical (ATC) classification index with defined daily doses (DDDs). World Health Organization, Oslo
11. Pedersen CB, Gøtzche H, Møller JØ et al (2006) The Danish Civil Registration system - a cohort of 8 million people. Dan Med Bull 53:441-449
12. Andrade SE, Kahler KH, Frech F et al (2006) Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 15:565-574
13. StataCorp (2009) Stata: release 11. Statistical software. StataCorp LP, College Station
14. www.medstat.dk/en (Medicine Sales in Denmark)
15. Referenceprogram for behandling af patienter med apopleksi (2009) Danish Health Board, 3rd edn. Available at: http://www.sst.dk/publ/Publ2010/Andre/ ReferenceprogramApopleksiDSFA.pdf
16. Nielsen LH, Løkkegaard E, Andreasen AH, Andersen Hundrup Y, Keiding N (2009) Estimating the effect of current, previous, and never use of drugs in studies based on prescription registries. Pharmacoepidemiol Drug Saf 18:147-153
17. Caetano PA, Lam JMC, Morgan SG (2006) Toward a standard definition and measurement of persistence with drug therapy: examples from research on statin and antihypertensive utilization. Clin Ther 28:1411-1424